Last reviewed · How we verify
NCT06073340: STIM-RAD
The Longitudinal Study of Stimulant Use Disorder
trial in Stimulant Use in 72 participants. Terminated before completion.
31 March 2025
Quick facts
| Lead sponsor | University of Texas Southwestern Medical Center |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 72 |
| Start date | 16 November 2023 |
| Primary completion | 31 March 2025 |
| Estimated completion | 31 March 2025 |
| Sites | 1 location across United States |
Conditions studied
- Stimulant Use — all drugs for Stimulant Use →
- Stimulant-Related Disorder — all drugs for Stimulant-Related Disorder →
- Healthy — all drugs for Healthy →
Sponsor
University of Texas Southwestern Medical Center
Who can join
Adults 18 to 85, any sex, with Stimulant Use or Stimulant-Related Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research is a 5-year observational, longitudinal registry study with no treatment or medication provided as part of participation. Individuals with current or lifetime stimulant use disorder, in addition to healthy control individuals, may be eligible to participate in this study. A variety of assessments and tasks including Magnetic Resonance Imaging (MRI), Electroencephalography (EEG), blood draws, urine drug screens, and both self-report and clinician-rated assessments will be used to assess biomarkers in this population. This study has a visit schedule of four in-person visits and eight remote visits per year.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06073340
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stimulant Use
Currently open trials in the same condition.
- NCT06814275 — Project neuroARTEMIS · NA · recruiting
- NCT05835921 — Enhancing Prospective Thinking in Early Recovery · NA · recruiting
- NCT04899024 — PrEP Affect Regulation Treatment Innovation · NA · active not recruiting
- NCT04426214 — Neuromodulation and Cognitive Training for Substance Use Disorders · NA · recruiting
- NCT03935646 — Acute Effects of Stimulant Medication in College Students With ADHD · Phase 2 · recruiting
Other University of Texas Southwestern Medical Center trials
Trials by the same sponsor.
- NCT03849963 — Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain · recruiting
- NCT06917183 — Developing Strategies for Implementation and Use of the Operating Room Black Box (ORBB) · NA · not yet recruiting
- NCT05145309 — Value of Potassium Magnesium Citrate in Preventing and Treating Hypertension in African Americans · Phase 2 · not yet recruiting
- NCT06552000 — Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer · NA · not yet recruiting
- NCT07387666 — Imaging Acetadote Metabolism in Glioblastoma · EARLY_PHASE1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06073340 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Texas Southwestern Medical Center
- Last refreshed: 8 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06073340.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing